13G Filing: Partner Fund Management and Pacira Pharmaceuticals Inc (PCRX)

Page 8 of 13

Page 8 of 13 – SEC Filing

CUSIP No. 695127100 13G Page
8 of 13 Pages
Item 1(a) Name of Issuer

Pacira Pharmaceuticals, Inc.

 

Item1(b) Address of Issuer’s Principal Executive Offices
5 Sylvan Way, Suite 300, Parsippany, New Jersey 07054

 

Item 2(a) Name of Person Filing
This Schedule 13G is being jointly filed by Partner Fund Management, L.P. (“PFM”), Partner Fund Management GP, LLC
(“PFM-GP”), Partner Investment Management, L.P. (“PIM”), Partner Investment Management GP, LLC (“PIM-GP”),
Brian D. Grossman (“Grossman”) and Christopher M. James (“James” and, collectively with PFM, PFM-GP, PIM,
PIM-GP and Grossman, the “Reporting Persons”) with respect to shares of common stock of the above-named issuer owned
by PFM Healthcare Master Fund, L.P., a Cayman Islands limited partnership (“HCM”), PFM Healthcare Opportunities Master
Fund, L.P., a Cayman Islands limited partnership (“HCOPP”), PFM Healthcare Principals Fund, L.P., a Delaware limited
partnership (“HCP”), PFM Healthcare Emerging Growth Master Fund, L.P., a Cayman Islands limited partnership (“HEGM”),
PFM Global Long Alpha Master Fund, L.P., a Cayman Islands limited partnership (“GLAM”), PFM Diversified Master Fund,
L.P., a Cayman Islands limited partnership (“DM”), PFM Diversified Institutional Master Fund, L.P., a Cayman Islands
limited partnership (“DIM”), and PFM Diversified Principals Fund, L.P. a Delaware limited partnership (“DP”
and, collectively with HCM, HCOPP, HCP, HEGM, GLAM, DM and DIM, the “Funds”).
PFM is the investment advisor for HCM, HCOPP, HEGM, GLAM, DM and DIM. PIM is the investment advisor for HCP and DP. PFM-GP
and PIM-GP are, respectively, the general partners of PFM and PIM. Grossman is the portfolio manager for the health care strategy
for the Funds. James is the portfolio manager for the diversified strategy for the Funds. Grossman and James are co-managing members
of PFM-GP and PIM-GP.
The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner
of any securities covered by the statement other than the securities actually owned by such person (if any).

 

Item 2(b) Address of Principal Business Office
The address of the principal business office of each of the Reporting Persons is c/o Partner Fund Management, L.P., 4 Embarcadero
Center, Suite 3500, San Francisco, CA 94111.

 

Item 2(c) Citizenship
Each of PFM and PIM is organized as a limited partnership under the laws of the State of Delaware. Each of PFM-GP and PIM-GP is
organized as a limited liability company under the laws of the State of Delaware. Each of Grossman and James is a U.S. citizen.
Item(d) Title of Class of Securities
Common stock, $0.001 par value

 

Item2(e) CUSIP Number
695127100

 

Follow Pacira Biosciences Inc. (NASDAQ:PCRX)

Page 8 of 13